Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
09/2014
09/18/2014WO2014140017A1 Novel process for the manufacture of 3-oxo-tetrahydrofuran
09/18/2014WO2014139963A1 Cosmetic compositions with tricyclodecane amides
09/18/2014WO2014139080A1 Novel process for the manufacture of 3-oxo-tetrahydrofuran
09/18/2014WO2014138823A1 Compounds and uses thereof in the treatment/prevention of gram-negative bacterial infections
09/18/2014US20140275583 Acid-functionalized nanoparticle catalyst and catalyzed reactions using the same
09/18/2014US20140275582 Chiral 2-arylpropyl-2-sulfinamide and chiral n-2-arylpropyl-2-sulfinylimines and synthesis thereof
09/18/2014US20140275581 Method and an arrangement for separating at least one carboxylic acid and furfural from a dilute aqueous mixture thereof
09/18/2014US20140275580 Glycitan esters of unsaturated fatty acids and their preparation
09/18/2014US20140275579 Novel process for the manufacture of 3-oxo-tetrahydrofuran
09/18/2014US20140275578 2-(alkoxy or aryloxy carbonyl)-4-methyl-6-(2,6,6-trimethylcyclohex-1- enyl)hex-2-enoic acid compounds, its preparation and use
09/18/2014US20140275573 Method of producing beraprost
09/18/2014US20140275400 Methylene beta-diketone monomers, methods for making methylene beta-diketone monomers, polymerizable compositions and products formed therefrom
09/18/2014US20140275238 Inhibition of neovascularization by inhibition of prostanoid ip receptors
09/18/2014US20140275172 Benzo-fused heterocyclic derivatives useful as agonists of gpr120
09/18/2014US20140275112 Compounds For Stabilizing Ryanodine Receptors From Aberrant Levels Of Calcium Release
09/18/2014US20140275093 Substituted hydroxamic acids and uses thereof
09/18/2014US20140275043 Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders
09/17/2014EP2776411A1 Modulators of c3a receptors
09/16/2014US8835691 Process for homogeneously catalyzed, highly selective direct amination of primary alcohols with ammonia to primary amines with a high volume ratio of liquid phase to gas phase and/or high pressures
09/16/2014US8835660 Method for extracting organic compounds from aqueous mixtures
09/16/2014US8835659 Polysubstituted benzofurans and medicinal applications thereof
09/16/2014US8835658 Asymmetric synthesis of norcantharidin analougus by alkynylation of oxabenzonorbornadienes and their anticancer activities
09/16/2014US8835657 Cyclopentanedione compounds and their use as insecticides, acaricides and/or fungicides
09/16/2014US8835639 Process for making modulators of cystic fibrosis transmembrane conductance regulator
09/16/2014US8835491 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
09/16/2014US8835472 Compounds, pharmaceutical compositions and uses thereof
09/16/2014CA2570680C Dibenzo[b]perhydroheterocyclic amines and lubricating oil compositions
09/12/2014WO2014137301A1 Hydrazones and thiazolidinones derived from diflunisal
09/12/2014WO2014135776A1 Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
09/12/2014WO2014135095A1 Dihydrobenzofuran derivatives as insecticidal compounds
09/12/2014WO2014118806A9 Single step process for conversion of furfural to tetrahydrofuran
09/11/2014US20140256967 Cerium-containing zeolites and coke reduction methods
09/11/2014US20140256966 Method to stabilize base metal catalysts by overcoating via atomic layer deposition and resulting product
09/11/2014US20140256965 Process for converting bio-oil
09/11/2014US20140256964 Oxidation process to produce a crude dry carboxylic acid product
09/11/2014US20140256963 Process for the preparation of aliskiren
09/11/2014US20140256782 Opsin-Binding Ligands, Compositions and Methods of Use
09/11/2014US20140256743 Cathepsin cysteine protease inhibitors
09/11/2014US20140256730 Treprostinil derivative compounds and methods of using same
09/11/2014US20140256698 Cathepsin inhibitors
09/11/2014DE102013003107A1 Naphthofurandione mit einer 1-Bromalkylgruppe oder einer 1-Hydroxyalkylgruppe in 2-Position und einer Alkylgruppe in 3-Position zum Furanring-Sauerstoff und Verfahren zu deren Herstellung Naphthofurandione with a 1-bromoalkyl group or a 1-hydroxyalkyl group at the 2-position and an alkyl group in the 3-position on the furan ring-oxygen and methods for their preparation
09/10/2014EP2774924A1 New compositions, cross-linkable rubber mixtures containing these compositions, process for their production and their use
09/10/2014EP2774917A1 Pharmaceutical composition for treating diabetes
09/10/2014EP2773630A1 Process for the production of hydrocarbons
09/10/2014EP2773437A1 A method and an arrangement for separating at least one carboxylic acid and furfural from a dilute aqueous mixture thereof
09/09/2014US8829783 Trinaphthyl monoamine or derivative thereof, organic electroluminescent device using the same, and organic electroluminescent material-containing solution
09/09/2014US8829209 Cycloalkylcarbonylamino acid ester derivative and process for producing the same
09/09/2014US8829033 N-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents
09/09/2014US8828903 Copper catalyst for dehydrogenation application
09/04/2014WO2014133361A1 Tricyclic compound and use thereof
09/04/2014WO2014131825A1 Pharmaceutical formulations comprising quetiapine and escitalopram
09/04/2014US20140249215 New salt of abexinostat, associated crystalline form, a process for their preparation and pharmaceutical compositions containing them
09/04/2014US20140249199 Tak1 kinase inhibitors, compositions, and used related thereto
09/03/2014EP2772522A1 Radical inhibitor
09/03/2014EP2772489A1 Hydrogenolysis of furfuryl alcohol to 1,2-pentanediol or to tetrahydrofurfuryl alcohol
09/03/2014EP2772485A1 Bicyclic compound
09/03/2014EP2771329A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
09/02/2014US8822708 Benzo-fused thiophene / triphenylene hybrid materials
09/02/2014US8822706 Method for preparing 2-hydroxybutyrolactone
09/02/2014US8822530 Sulfur derivatives as chemokine receptor modulators
09/02/2014US8822527 Substituted biaryl alkyl amides
09/02/2014US8822383 Germination-stimulant carbamate derivatives and process for preparation thereof
09/02/2014US8822041 Anthracene derivatives, luminescent materials and organic electroluminescent devices
09/02/2014US8821804 Use of particle filters for limiting catalyst deactivation
09/02/2014CA2602467C Bcrp/abcg2 inhibitor
08/2014
08/28/2014WO2014129846A1 Organic electroluminescent compounds and an organic electroluminescent device comprising the same
08/28/2014WO2014129612A1 Process for producing pyridazinone compound and production intermediates thereof
08/28/2014WO2014128723A2 Anticancer compounds and process for the preparation thereof
08/28/2014WO2014066613A3 Sphingolipid metabolite mimetics
08/28/2014US20140243562 Hydrogenolysis of furfuryl alcohol to 1,2-pentanediol
08/28/2014US20140243310 Bicyclic compound
08/28/2014US20140239230 Reduction of hmf ethers with metal catalyst
08/27/2014EP2768799A1 Substituted biaryl alkyl amides
08/26/2014US8816104 Process
08/26/2014US8816103 Process for the preparation of dronedarone
08/26/2014US8816101 Paraconic acids as pigmentation activators
08/26/2014US8815999 Cross-linker
08/26/2014US8815943 Modulation of bacterial quorum sensing with synthetic ligands
08/26/2014US8815924 Heterocyclic carbonyl compounds
08/26/2014US8815915 Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators
08/26/2014US8815864 Indanyloxydihydrobenzofuranylacetic acids
08/26/2014US8815852 Carbamoyloxy arylalkan arylpiperazine analgesics
08/26/2014CA2653039C Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
08/26/2014CA2611443C Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
08/21/2014WO2014125075A1 Albicidin derivatives, their use and synthesis
08/21/2014US20140235881 Method for producing 5-hydroxymethyl-2-furfural or alkyl ether derivatives thereof using an ion exchange resin in the presence of an organic solvent
08/21/2014US20140235880 Process for purifying crude furan 2,5-dicarboxylic acid using hydrogenation
08/21/2014US20140235879 Orally dispersible tablet
08/21/2014US20140235683 Compositions and Methods for the Treatment of Norovirus Infection
08/21/2014US20140235650 Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
08/21/2014US20140235533 Dihydrofuran derivatives as insecticidal compounds
08/20/2014EP2767539A1 Pseudopolymorphic forms of a HIV protease inhibitor
08/20/2014EP2767533A1 Derivative of butylphthalide and preparation method and use thereof
08/20/2014EP2766351A1 Production of 5-hydroxymethylfurfural from fructose using a single-phase mixed aqueous-organic solvent system
08/20/2014EP2766350A1 Selective androgen receptor modulators
08/19/2014US8809556 Oxidation process to produce a purified carboxylic acid product via solvent displacement and post oxidation
08/19/2014US8809491 Depolymerization of oligomeric cyclic ethers
08/19/2014US8809376 Indanyloxydihydrobenzofuranylacetic acids
08/19/2014CA2634749C Process for preparing a synthetic intermediate for preparation of branched nucleosides
08/19/2014CA2625034C 3-alkyl-5-(4-alkyl-5-oxo-tetrahydrofutran-2-yl)pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 472